The Role of HMGB-1 in Chronic Stroke

Stopped early

Conditions studied: Cerebrovascular Accident, Cerebral Stroke, Stroke, Acute

In brief

The purpose of this study is to measure the presence of HMGB-1 and other proteins in the blood across five time points after stroke, and to determine if their presence correlates with rate of stroke recovery.

Key facts

Study ID

NCT01705353

Run by

Northwell Health

People needed

39

Starts

2012-09-01

Expected to finish

2018-02-01

Last updated by the study team

2018-03-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients admitted to the stroke service at Northshore and LIJ Medical Centers
• Patients 18 years of age or older

You may not qualify if…

• Patients < 18 years of age

Where it is running

• North Shore University Hospital — Manhasset, New York, United States
• Long Island Jewish Medical Center — New Hyde Park, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.